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The surface of the intestinal mucosa is constantly assaulted by food antigens 
and enormous numbers of commensal microbes and their products, which are 
sampled by dendritic cells (DCs). Recent work shows that the mesenteric 
lymph nodes (MLNs) are the key site for tolerance induction to food proteins 
and that they also act as a fi  rewall to prevent live commensal intestinal 
bacteria from penetrating the systemic immune system.
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Systemic tolerance to food antigens
It has been known for nearly a century 
that feeding rodents with a protein 
blunts subsequent responses to systemic 
challenge with the same protein (1). 
This phenomenon is termed oral toler-
ance and has been extensively studied 
using soluble proteins fed to rodents 
(Fig. 1), although it can be induced in 
other species including humans (2), 
with a variety of T-dependent antigens, 
and also via the nasal mucosa (3). The 
paper by Worbs et al. in this issue 
(p. 519) provides new insights into the 
anatomy of intestinal oral tolerance (4). 
They show that tolerance is induced 
exclusively in the MLNs after migra-
tion of antigen-loaded DCs from the 
intestinal mucosa.
Some of the battery of food anti-
gens taken with every meal are ab-
sorbed as proteins or protein fragments 
and reach secondary lymphoid struc-
tures via lymph and blood (5). Oral 
tolerance can give us insight into the 
crosstalk between mucosal surfaces and 
the systemic immune system, in partic-
ular how hypersensitivity to food com-
ponents is normally avoided. In oral 
tolerance models, cell-mediated and 
humoral (IgE, IgG, and IgM) responses 
are tolerized (6, 7). The resulting sys-
temic hyporesponsiveness is dependent 
on CD4+ T cells, because CD4+ T cell 
depletion abrogates the eff  ect (8), and 
adoptive transfer of these cells into a 
naive animal transfers the tolerance (9). 
Tolerized T cells are unable to provide 
cognate B cell help (10), and B cells 
are tolerized by the absence of T cell 
help (11).
The mechanisms that produce T 
cell hyporesponsiveness after antigen 
feeding are complex and depend to 
some extent on experimental setup and 
antigen dose (3). The importance of 
DCs in tolerance induction has been 
shown in vivo: mice treated with the 
cytokine fl  t3 ligand (fl  t3L) to increase 
DC numbers are more susceptible to 
oral tolerance (12). Hyporesponsiveness 
can be the result of direct inactivation 
of lymphocytes (deletion or anergy) or 
modulation through regulatory T (T 
reg) cell populations. If very high doses 
of antigen are given to T cell receptor 
transgenic mice, the antigen-specifi  c T 
cells are clonally deleted, although how 
important this is in physiological cir-
cumstances is uncertain (13). T cell un-
responsiveness (anergy) is induced in 
models where lower doses of antigen 
and lower frequencies of antigen-spe-
cifi  c T cells are used (14, 15). CD4+ T 
reg cells are also involved in oral toler-
ance: CD4+ T cells producing the sup-
pressive cytokine TGFß (T helper type 
3 cells) (16) and CD4+ CD25+ FoxP3+ 
T reg cells have both been reported to 
be induced by antigen feeding (17). The 
relative role that these diff  erent mecha-
nisms play in physiological tolerance to 
normal food antigens is still unclear.
Oral tolerance can be induced 
in the systemic immune system
Although diff   erent experiments give 
diff  erent answers about the mechanisms 
of T cell hyporesponsiveness, perhaps 
refl  ecting several diff  erent methods of 
tolerization, we still have the question of 
where tolerization is taking place. It is 
intuitive that oral tolerance should be 
induced locally in the mucosal immune 
system, but we must remember that the 
readout is an attenuated systemic im-
mune response after parenteral immuni-
zation (Fig. 1). There is no reason why 
systemic tolerance cannot be induced by 
a food antigen that enters the vascular 
circulation through tributaries of the he-
patic portal vein and reaches peripheral 
secondary lymphoid structures via the 
circulation (Fig. 2). Indeed, there is evi-
dence that this happens, and we will fi  rst 
examine some of these experiments.
To pinpoint the site of tolerization, 
the earliest eff  ects of fed antigen on 
T cells have been examined by transfer-
ring TCR transgenic T cells specifi  c for 
ovalbumin and then giving an oral dose 
of antigen (18). These experiments 
showed that antigen-specifi  c T cells in 
MLNs and peripheral lymph nodes di-
vided with similar kinetics at early times 
during the tolerization protocol, indi-
cating that oral antigen has early eff  ects 
on T cells in the periphery as well as in 
the mucosa. In a follow-up study, the 
same workers assessed in vivo T cell 
  behavior in lymph nodes in real time, 
during the induction of oral tolerance 
or priming (19). They found that oral 
tolerization led to smaller, more tran-
sient T cell clustering around the anti-
gen-presenting cells (APCs) compared 
with the larger more stable clusters 
formed after immunization. Again, the 
eff   ects of tolerization could be seen 
both in the mesenteric and peripheral 
lymph nodes with similar kinetics, sug-
gesting that tolerance can be triggered 
both mucosally and systemically.
Two older observations indirectly 
suggest that oral tolerance can be in-
duced outside mucosal lymphoid struc-
tures. First, transfer of serum from 
tolerized mice, presumably containing 
processed antigen, can induce   tolerance 
in a recipient animal (20). The serum 
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was injected into the peritoneum; thus, 
the antigen would mostly be cleared into 
the circulation, the spleen, and systemic 
lymph nodes. Follow-up experiments 
showed that oral tolerance could be 
blocked in these experiments by treat-
ment of the recipients with the immu-
nosuppressant cyclophosphamide after 
serum transfer, suggesting that toleriza-
tion was the result of an active immune 
response to gut processed antigen that 
had been absorbed into the blood and 
transferred with the serum (21). Second, 
it is well established that antigen given 
directly into the hepatic portal vein 
  induces systemic tolerance (22).
MLNs are the key site for oral 
tolerance induction
Although some tolerization could take 
place systemically after antigen feeding, 
there has been no reason to doubt that it 
takes place largely within the local mu-
cosal immune system. Of the local lym-
phoid tissues, it appears that the MLN 
are the main site for oral tolerance in-
duction. Presentation of fed   antigens 
occurs preferentially in the MLN rather 
than the Peyer’s patches, which are 
small lymphoid structures on the intesti-
nal wall (23). Oral tolerance cannot be 
induced in mice lacking MLN (and pe-
ripheral lymph nodes), but it is unaf-
fected in mice that lack only Peyer’s 
patches (24). Furthermore, it has been 
shown that DCs constitutively traffi   c 
from the intestinal epithelium and Peyer’s 
patches to the MLN, so there is a clear 
mechanism whereby antigen can be 
picked up at the intestinal epithelial sur-
face and taken to the MLN (25), where 
T cell tolerization can occur.
The paper by Worbs et al. (4) ele-
gantly shows that in clean mice the 
MLN are an obligatory and exclusive 
site of oral tolerance induction. TCR 
transgenic T cells transferred into naive 
mice were seen to proliferate at day 
2 after antigen feeding in the MLN, but 
not until day 4 in peripheral lymph 
nodes. Using either the drug FTY720 
or surgical excision of the MLN to 
block T cell egress from MLN, they 
showed not only that antigen-specifi  c 
T cells in systemic lymph nodes were 
the progeny of migrants from MLN, 
but also that oral tolerance to a systemic 
immunization challenge depends on 
MLN T cell migrants.
The authors then used two experi-
mental systems to show that antigen-
laden DCs migrating from the intestinal 
wall to the MLN can tolerize MLN-
  resident T cells. First, in an   animal with 
an intestinal transplant in which the vas-
cular supply is anastomosed to the host, 
but the lymphatic system is separate, an 
oral protein challenge caused T cells only 
in the host and not the graft MLN to be 
stimulated. Second, in mice defi  cient for 
the chemokine receptor CCR7, which 
have impaired DC migration to MLN, 
both T cell stimulation and functional 
oral tolerance were abrogated. These 
experiments allowed them to conclude 
that oral tolerance is exclusively gener-
ated in the MLN with antigen trans-
ported from the intestinal surface by DCs 
through the aff  erent lymphatics (Fig. 2).
Although Worbs et al. see no evi-
dence for direct peripheral tolerization, 
they do show that intravenous protein 
at a dose 100-fold lower than that given 
for oral tolerance drives proliferation 
equivalently in peripheral lymph nodes 
and MLNs. The dose of antigen reaching 
the systemic circulation is not measured 
directly in most oral tolerance experi-
ments, but it is reasonable to assume that 
antigen reaches the vasculature in some 
experimental scenarios (for instance, in 
the presence of low grade enteropathy 
accompanying a diff  erent hygiene sta-
tus) to account for early systemic T cell 
proliferation seen in some studies. Oral 
tolerance induction is clearly MLN cen-
tric in very clean mice; but the intes-
tinal epithelial barrier remains thin and 
vulnerable, so some hepatic or systemic 
tolerization may compensate when anti-
gen escapes into the blood stream.
MLNs preserve systemic ignorance 
to commensal bacteria
Food antigens are certainly not the 
only immunogenic load in the gut. The 
Figure 1.  Induction of oral tolerance. To induce oral tolerance animals are fed with soluble pro-
tein (such as ovalbumin; OVA). Tolerance can be induced with single high doses, typically 100 mg, or 
several repeated low doses, typically 1–25 mg. Control animals are fed PBS. 2 weeks after feeding 
animals are injected subcutaneously with protein in adjuvant (such as OVA with complete Freund’s 
adjuvant; CFA). 2–3 weeks after subcutaneous priming, animals are challenged with heat- aggre-
gated protein in the ear or footpad. Changes in footpad or ear thickness are then recorded, usually 
24 or 48 h after challenge (delayed type hypersensitivity; DTH). Tolerized animals exhibit reduced DTH 
reactions. Antibody responses are assessed after serum collection, and in vitro techniques, such as 
antigen-stimulated thymidine incorporation, are used to assess T cell responses. Using these read-
outs both B and T cell responses are attenuated in tolerized animals.COMMENTARY
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nonpathogenic microbes in the lower 
intestine outnumber our body’s own 
cells, and the dramatic increases of IgA-
secreting plasma cells and lamina propria 
CD4+ cells after the colonization of 
germ-free animals with intestinal bac-
teria attest to the way in which the 
  immune system adapts to help us live 
harmoniously with these organisms. 
Oral tolerance is not as eff  ective for par-
ticulate antigens as it is for soluble pro-
teins, and live bacteria are extremely 
immunogenic. Fortunately, despite the 
very high loads of commensal bacteria 
present in the intestine, the systemic im-
mune system of clean mice is ignorant 
of these bacteria, although it can be very 
easily primed by small (104–106 colony-
forming units) doses of live commensals 
given intravenously (26). This compart-
mentalized setup is useful because it 
achieves strong local mucosal responses 
without needing to tolerize the systemic 
immune system and hence suppress its 
ability to respond to systemic sepsis from 
a commensal or a closely related patho-
gen. MLNs are also a key part of this 
immune geography, but here they act as 
a fi  rewall to preserve systemic ignorance 
of commensal organisms, rather than an 
obligatory site for induction of the adap-
tive response itself.
IgA+ B cells are induced by intesti-
nal DCs that have sampled commensal 
intestinal bacteria (27). These B cells 
then recirculate through the lymph and 
blood to populate the intestinal lamina 
propria with IgA-secreting plasma 
cells. Induction of IgA+ B cells occurs 
mostly in the Peyer’s patches, and mice 
which have had their MLN removed 
show normal in vivo IgA responses 
against intestinal doses of commensals. 
Although a small proportion of an in-
testinal challenge dose of commensal 
bacteria does get carried to the MLNs 
by intestinal DCs, commensal-laden 
DCs do not penetrate further into the 
thoracic duct lymph or reach the sys-
temic circulation (Fig. 2). Thus, the 
MLNs are the fi  rewall that stops con-
stant systemic penetration and priming 
by these abundant intestinal microbes. 
Any bacteria released by dying DCs are 
probably very quickly eliminated by 
MLN macrophages. In animals without 
MLNs that are repeatedly challenged 
with intestinal bacterial, commensal-
laden DCs pass into the thoracic duct 
and allow live bacteria to reach the 
circulation, causing systemic priming 
with massive splenomegaly and lymph-
adenopathy (27).
We generally perceive ourselves as 
free-living metazoa, occasionally assaulted 
by pathogens, but this is an illusion. We 
need to eat, and our bodies must live in 
harmony with our intestinal commensal 
microbes. The MLNs are central to this 
mutualism, providing a site of tolerance
Figure 2.  Functional anatomy of induction of immune responses by intestinal antigens. 
Abundant protein antigens and live commensal bacteria are present in the intestine. Antigenic 
  peptides can pass into the bloodstream through one of the tributaries of the hepatic portal vein or 
are taken up by DCs in the subepithelial region of the Peyer’s patches and carried to the MLNs via the 
afferent lymphatics. Although it is possible for circulating peptides to tolerize T cells in the liver or 
peripheral lymph  nodes, presentation in the MLNs is the dominant tolerogenic pathway. Commensal 
bacteria are also sampled by intestinal DCs and induce IgA responses in the Peyer’s patches; 
  although very small numbers of commensals can be carried to MLN by DC, systemic   tolerance to 
these organisms is not induced. Because the commensal laden DCs do not penetrate   further than the 
MLN, the systemic immune system is protected from unwanted priming reactions from live bacteria.500  MESENTERIC LYMPH NODES AT THE CENTER OF IMMUNE ANATOMY | A.J. Macpherson and K. Smith
induction to soluble proteins and a 
fi  rewall against our commensal passen-
gers. Most of the body’s lymphocytes 
and antibody production are actually in 
the gut, so the MLNs are at a pivotal 
position in immune anatomy and im-
migration control, forming the border 
crossing between mucosal immunity 
and the remainder of immune system.
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